AU2003285485A1 - 5 ANDROSTEN-3Beta-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION - Google Patents

5 ANDROSTEN-3Beta-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION

Info

Publication number
AU2003285485A1
AU2003285485A1 AU2003285485A AU2003285485A AU2003285485A1 AU 2003285485 A1 AU2003285485 A1 AU 2003285485A1 AU 2003285485 A AU2003285485 A AU 2003285485A AU 2003285485 A AU2003285485 A AU 2003285485A AU 2003285485 A1 AU2003285485 A1 AU 2003285485A1
Authority
AU
Australia
Prior art keywords
androsten
3beta
processes
preparation
steroid intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003285485A
Other languages
English (en)
Inventor
Doris Beck
Michael J. White
Peter G. M. Wuts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co LLC
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of AU2003285485A1 publication Critical patent/AU2003285485A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003285485A 2002-08-16 2003-03-21 5 ANDROSTEN-3Beta-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION Abandoned AU2003285485A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40399002P 2002-08-16 2002-08-16
US60/403,990 2002-08-16
US41529302P 2002-10-01 2002-10-01
US60/415,293 2002-10-01
PCT/US2003/007791 WO2004016640A2 (en) 2002-08-16 2003-03-21 5 ANDROSTEN-3β-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION

Publications (1)

Publication Number Publication Date
AU2003285485A1 true AU2003285485A1 (en) 2004-03-03

Family

ID=31891414

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003285485A Abandoned AU2003285485A1 (en) 2002-08-16 2003-03-21 5 ANDROSTEN-3Beta-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION

Country Status (12)

Country Link
US (2) US20040034215A1 (enExample)
EP (1) EP1534732B1 (enExample)
JP (1) JP2006507369A (enExample)
AT (1) ATE339437T1 (enExample)
AU (1) AU2003285485A1 (enExample)
BR (1) BR0313523A (enExample)
CA (1) CA2495412A1 (enExample)
DE (1) DE60308388T2 (enExample)
ES (1) ES2271636T3 (enExample)
MX (1) MXPA05001857A (enExample)
TW (1) TW200406419A (enExample)
WO (1) WO2004016640A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20042338A1 (it) * 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
US8084446B2 (en) * 2005-04-26 2011-12-27 Eric Marchewitz Use of DHEA derivatives for enhancing physical performance
PL2527356T3 (pl) * 2005-07-21 2018-06-29 Bayer Intellectual Property Gmbh Sposób wytwarzania 3-okso-pregn-4-eno-21,17-karbolaktonów za pomocą wolnego od metali utleniania 17-(3-hydroksypropylo)-3,17- dihydroksyandrostanów
ATE403668T1 (de) 2005-07-21 2008-08-15 Bayer Schering Pharma Ag Verfahren zur herstellung von 3-oxo-pregn-4-en-21,17-carbolactonen durch die metallfreie oxidation von 17-(3-hydroxypropyl)-3,17- dihydroxyandrostanen
US7319154B2 (en) 2005-07-21 2008-01-15 Bayer Schering Pharma Ag Process for the production of 3-oxo-pregn-4-ene-21, 17-carbolactones by the metal free oxidation of 17-(3-hydroxypropyl)-3, 17-dihydroxyandrostanes
CN110331182A (zh) * 2019-08-06 2019-10-15 江苏远大仙乐药业有限公司 一种甾体中间体的生物转化制备方法
CN110885869A (zh) * 2019-12-24 2020-03-17 天津科技大学 一种利用微生物转化生产7α-羟基-脱氢表雄酮的方法
CN111057734A (zh) * 2019-12-24 2020-04-24 天津科技大学 一种甲基睾丸素高效转化生产11α-羟基-甲基睾丸素的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3294646A (en) * 1963-10-23 1966-12-27 American Home Prod Microbiological hydroxylation of norsteroids using aspergillus ochraceus
DE2349022A1 (de) * 1973-09-26 1975-04-10 Schering Ag Neue d-homo-steroide
DK134348C (da) * 1973-11-30 1977-03-21 Schering Ag Analogifremgangsmade til fremstilling af d-homo-20-ketopregnaner
US4031074A (en) * 1974-09-02 1977-06-21 Akzona Incorporated Process for the preparation of 11β-hydroxy-18-alkyl-estrane compounds
IL48628A0 (en) * 1974-12-23 1976-02-29 Schering Ag D-homo-20-keto-pregnanes and process for their manufactur
US4054563A (en) * 1975-04-25 1977-10-18 Ciba-Geigy Corporation Process for the manufacture of spiro compounds of the steroid series
CH633562A5 (de) * 1976-12-10 1982-12-15 Schering Ag Verfahren zur herstellung neuer kortikoide.
US4336332A (en) * 1979-02-20 1982-06-22 Hoffmann-La Roche, Inc. Process for the manufacture of hydroxylated steroids
DE3042136A1 (de) * 1980-11-03 1982-06-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur herstellung von 3 (beta), 7 (beta) -dihydroxy- (delta) (pfeil hoch)5(pfeil hoch) -steroiden
US4559332A (en) * 1983-04-13 1985-12-17 Ciba Geigy Corporation 20-Spiroxanes and analogues having an open ring E, processes for their manufacture, and pharmaceutical preparations thereof
AU7978794A (en) * 1993-10-13 1995-05-04 Neurocrine Biosciences, Inc. 3,17-dihydroxy-3,7,16 and/or 17-methyl-androst-5-ene compounds, derivatives thereof, and their use
PT973791E (pt) * 1995-12-11 2007-09-26 Searle Llc Processo para a preparação de um composto epoxi
DE69620474T2 (de) * 1995-12-12 2002-11-14 Akzo Nobel N.V., Arnhem Mikrobielle 11alpha-hydroxylierung von steroiden
FR2771105A1 (fr) 1997-11-20 1999-05-21 Vitasterol Utilisation du fusarium monoliforme pour la preparation des derives 7alpha-hydroxyles de la dehydroepiandrosterone et de la pregnenolone

Also Published As

Publication number Publication date
JP2006507369A (ja) 2006-03-02
MXPA05001857A (es) 2005-06-03
WO2004016640A3 (en) 2004-07-08
BR0313523A (pt) 2005-06-28
CA2495412A1 (en) 2004-02-26
DE60308388T2 (de) 2007-09-20
US20040034215A1 (en) 2004-02-19
EP1534732A2 (en) 2005-06-01
US7002028B2 (en) 2006-02-21
ES2271636T3 (es) 2007-04-16
WO2004016640A2 (en) 2004-02-26
US20040220158A1 (en) 2004-11-04
ATE339437T1 (de) 2006-10-15
DE60308388D1 (de) 2006-10-26
TW200406419A (en) 2004-05-01
EP1534732B1 (en) 2006-09-13

Similar Documents

Publication Publication Date Title
AU2003247798A1 (en) Nozzles and components thereof and methods for making the same
AU2003299585A1 (en) Water-soluble products and methods of making and using the same
AU2003299791A1 (en) Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
EP1208085A4 (en) BENZANILIDE AS THE OPENER OF THE POTASSIUM CHANNEL
AU2003265859A1 (en) Assays and compositions for identifying agents that modulate the activity of deubiquitinating agents
WO2003099217A3 (en) Methods of treating bacterial infections and diseases associated therewith
WO2003102012A3 (en) New etonogestrel esters
AU2003265589A1 (en) Process for the preparation of 1,1,1,2,2-pentafluoroethane
AU2003288023A1 (en) Process for the manufacture of 1,2-epoxy-3-chloropropane
AU2003290592A1 (en) Antitumor benzoylsulfonamides
WO2003092632A3 (en) Cyclic peptide anti-cancer agents and methods
AU6279500A (en) Epothilone compositions
AU2003285485A1 (en) 5 ANDROSTEN-3Beta-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION
AU2003233222A1 (en) Aqueous polyurethane preparations
AU2003206367A1 (en) Technical field of the invention
AU2003260983A1 (en) Processes for the preparation of s-(-)-amlodipine
AU2003245663A1 (en) Process for the enzymatic resolution of 1,3-dioxolane-4-carboxylates
AU2003292939A1 (en) Angiogenic compounds and uses thereof
AU6186499A (en) Agents for the immunotherapy of tumoral diseases
AU2002241185A1 (en) Quantitative detection of the conformation changes of p-glycoprotein
AU2003259159A1 (en) N-aryl-2-oxazolidinones and their derivatives
AU2002330245A1 (en) Isolated polypeptides and compositions from the venom of p. transvaalicus and methods of use
AU2002361488A1 (en) Field and background of the invention
AU2003278748A1 (en) Chemotherapy method using-rays background of the invention
AU2002355993A1 (en) Resuscitation of not immediately culturable bacteria

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase